Participants:18–64 years · 65+ years
Substances:Human Adenovirus C Serotype 5 With E1 Gene Controlled By Chromogranin A Promoter And Hexon Modified With Protein Transduction Domain Motif
Sponsor:Uppsala University

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Registered drugNo placebo

Study Comparing CPX-351 and Conventional Drug Combination for Patients with High-Risk Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia Before Stem Cell Transplant

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Azacitidine
Sponsor:GWT-Tud GmbH

Contact Research Centre

Mantle cell lymphoma

Not recruiting

InvestigationalNo placebo

Study on Obinutuzumab, Venetoclax, and Ibrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ibrutinib
Sponsor:Centre Hospitalier Universitaire De Nantes

Contact Research Centre

Substances studied in this area

The therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.

Pembrolizumab460 clinical trials Carboplatin339 clinical trials Cisplatin284 clinical trials Paclitaxel263 clinical trials Fluorouracil237 clinical trials Oxaliplatin227 clinical trials Nivolumab216 clinical trials Dexamethasone169 clinical trials Bevacizumab163 clinical trials

Neoplasms benign, malignant and unspecified (incl cysts and polyps) – page 319

Conditions in this area

Clinical trials in Neoplasms benign, malignant and unspecified (incl cysts and polyps)

3 896 clinical trials

Plasma cell myeloma

Study of Belantamab Mafodotin, Carfilzomib, and Dexamethasone for Patients with Relapsed Multiple Myeloma Resistant to Lenalidomide

Acute myeloid leukaemia+1

Study on Decitabine and Drug Combination for Elderly Patients with Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Waldenstrom's macroglobulinaemia

Study on the Effectiveness of Bortezomib, Rituximab, and Ibrutinib for Patients with Newly Diagnosed Waldenström’s Macroglobulinemia

Breast cancer metastatic+2

Study Comparing Oral Paclitaxel (DHP107) and IV Paclitaxel for Patients with Recurrent or Metastatic HER2 Negative Breast Cancer

Acute myeloid leukaemia

Study on Venetoclax, Cytarabine, and Mitoxantrone for Adults with Relapsed or Refractory Acute Myeloid Leukemia (AML) Eligible for Intensive Treatment

Sarcoma

Study on the Effectiveness of Nivolumab, Ipilimumab, and Pazopanib in Patients with Advanced Rare Sarcomas

Plasma cell myeloma

Study on Isatuximab, Lenalidomide, and Dexamethasone for Elderly Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Acute myeloid leukaemia+1

Study of ASTX727 and Donor Lymphocyte Infusions for Patients with High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia After Stem Cell Transplant

Small intestine adenocarcinoma

Study on the Effectiveness of Chemotherapy with Fluorouracil, Capecitabine, and Oxaliplatin for Patients with Small Bowel Adenocarcinoma

Neuroendocrine carcinoma metastatic

Study of AdVince (Modified Adenovirus) Treatment Through Hepatic Artery Injection in Patients with Advanced Neuroendocrine Neoplasms

Acute myeloid leukaemia+1

Study Comparing CPX-351 and Conventional Drug Combination for Patients with High-Risk Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia Before Stem Cell Transplant

Mantle cell lymphoma

Study on Obinutuzumab, Venetoclax, and Ibrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.